Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance
Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance…
Lucid Diligence Brief: Dayra Therapeutics, Versant Ventures and Biogen collaboration
Lucid Diligence Brief: Dayra Therapeutics, Versant Ventures and Biogen…
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
Lucid Diligence Brief: Electra Therapeutics $183M Series C
Lucid Diligence Brief: Electra Therapeutics $183M Series C Professional…
Lucid Diligence Brief: EVOQ x Sanofi collaboration
Lucid Diligence Brief: EVOQ x Sanofi collaboration Professional audiences only.…
Immunology Today: Zenas MS Deal, J&J FDA Approvals (Oct 8–15, 2025)
This week’s immunology news update includes Zenas BioPharma securing global…
Lucid Diligence Brief: Excellergy ECRIs, $70M investment
Lucid Diligence Brief: Excellergy ECRIs, $70M investment Professional audiences…
Neuroscience Weekly News - September 17th 2025
🧠 This Week in Neuroscience: RNAi Tau Therapy CTA, MS Patent Win, Generic…
AAAAI 2025 Preview: Key Allergy, Asthma and Immunology Highlights to Watch
AAAAI 2025 at a glance As AAAAI 2025 approaches, LucidQuest highlights…
Navigating the Immunoglobulin Therapy Landscape: An Overview
The Immunoglobulin Replacement Therapy (IG) market is growing, as these…
